Skip to main content

4572 · Carna Biosciences, Inc. · Financials

315 JPY -20 (-5.97%) At close · Nov 13
Market Cap
6.66B JPY
Shares
21.15M
Volume · Nov 13 437.9K Avg daily vol (3M) 193.71K

Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.

Revenue
579.06M -9%
FY2025 Revenue FY2021–FY2025
Net Income
-2.17B +0.3%
FY2025 Net Income FY2021–FY2025
Gross Margin
67.03% -6.2pp
FY2025 Gross Margin FY2021–FY2025
Operating Margin
-358.34% -32pp
FY2025 Operating Margin FY2021–FY2025
Operating Cash Flow
-2.16B -57.1%
FY2025 Operating Cash Flow FY2021–FY2025

Chart any reported metric, KPI or segment over time — the full statement history lives here

Line Item FY2025 FY2024 FY2023 FY2022 FY2021
JPY 579.06M 636.24M 1.63B 1.39B 2.02B
JPY 190.91M 170.54M 175.29M 171.55M 135.39M
JPY 388.15M 465.69M 1.45B 1.22B 1.88B
JPY -2.07B -2.08B -1.12B -1.27B -531.14M
JPY -2.17B -2.17B -1.13B -1.32B -532.5M
JPY 1.85M 4.6M 22.05M 26.14M 1.98M
JPY -2.17B -2.18B -1.15B -1.35B -534.47M
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.

Debt Profile

No verified debt profile is available yet. This does not establish that the company has no debt or covenants.